Board of Directors
| Martin D. Madaus, Ph.D | Chairman of the Board, President and Chief Executive Officer |
| John F. Reno | Retired Chairman, President and Chief Executive Officer, Dynatech Corporation |
| Professor Dr. Daniel Bellus | University of Fribourg, Switzerland |
| Edward M. Scolnick | Senior Associate Member Broad Institute, Massachusetts Institute of Technology (MIT) and Harvard University |
| Robert C. Bishop | Chairman of the Board, AutoImmune, Inc. |
| Karen E. Welke | Retired Group Vice President, Medical Markets Group of 3M Corporation |
| Maureen A. Hendricks | Former Managing Director, Salomon Smith Barney, Inc. |
| Melvin D. Booth | Retired President and Chief Operating Officer, Medlmmune |
| Mark Hoffman | Independent Investor and Consultant |
| Rolf Classon | Interim President and Chief Executive Officer of Hillenbrand Industries |
 | |
IR Contact
Contact for shareholders, potential investors and financial media.
Joshua S. Young
Director, Investor Relations
Tel: 978-715-1527
Joshua_Young@millipore.com
Millipore Contact InformationIR Services
Sign up for company alerts and download reports.
FAQs
Email Subscriptions
Download Documents
Order ReportsSafe Harbor Statement
The information on the Millipore investor relations website, as well as in future oral and written statements by management of Millipore Corporation that are forward-looking statements, are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements.
» More